Happy Holidays to One and All | GxP Perspectives

Happy Holidays to One and All

Happy Holidays

It’s the time of the year to think of families, fun, and maybe those less fortunate than ourselves. Whatever holiday you celebrate, I hope that it is super. We have a Guest Commentary coming Monday on the controversial decision regarding Plan B by DHHS Secretary Sebelius. Then we will have end of year wrap ups on Warning Letters for Active Pharmaceutical Ingredients, Clinical Investigators, and Sponsors. GxP Perspectives has a new Editorial Intern, Francesca Carreras-Velez. We’ll see what she has to say! As always, I am looking for Guest Commentaries. For more info, please leave me a message.

Happy Holidays One and All!

Carl Anderson, GxP Perspectives

This entry was posted on Friday, December 23rd, 2011 at 2:42 PM and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s

Top Posts
- Clinical Trial Protocol Deviations & Violations- Part II
- CAPA Plans for Clinical Trials
- FDA & EU Requirements for Documentation & Approval of GMP Procedures
- Clinical Trials in India: An Overview
- Receive Your FDA Establishment Inspection Report (EIR) using FMD-145
- GxP Defined: Training for FDA Regulated Industry
- FDA Releases Draft Guidance for Monitoring Clinical Trials
- CAPA Basics- Corrective And Preventative Action
- Clinical Trial Compliance & Checklists: The Right Approach?
- Drug Accountability in Clinical Trials
- FDA 1572: Big Changes in FAQ Information Sheet Guidance
- India: Quality for Clinical Trials
Search Blog

Search
Recent Posts
- GxP Perspectives Calls it a Day
- Three Things That You Should Know About Part 11
- FDA & EMA Regulatory Developments for eSubmissions
- FDA IP Labeling Requirements
- Quantifying Quality for GxP Compliance
- FDA & Politics: In the Interest of Science?
- TMF Reference Model Update
- India: Quality for Clinical Trials
- European Qualified Persons & New EU Anti-Falsification Legislation
- Drug Accountability in Clinical Trials
- FDA Warning Letters for International APIs in 2011
- Commentary on Plan B Controversy
- Happy Holidays to One and All
- A Better FDA? Why Not?
Top Rated
Calendar

December 2011

M T W T F S S

« Nov Jan »

1 2 3 4

5 6 7 8 9 10 11

12 13 14 15 16 17 18

19 20 21 22 23 24 25

26 27 28 29 30 31
Top Clicks
- fda.gov/ICECI/Enforcement…
- carl1anderson.files.wordp…
- fda.gov/ICECI/Enforcement…
- fda.gov/ICECI/Enforcement…
- fda.gov/ICECI/Enforcement…
- fda483s.com/2011/03/form-…
- carl1anderson.files.wordp…
- carl1anderson.files.wordp…
- fda.gov/ICECI/Enforcement…
- carl1anderson.files.wordp…
- accessdata.fda.gov/SCRIPT…
- carl1anderson.files.wordp…
topics
RSS
- RSS - Posts
- RSS - Comments
Pages
- About GxP Perspectives
- Articles & Book Reviews
- Guest Commentary
- Guide
- TMF
Email Subscription

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 601 other followers
RSS
- GxP Perspectives Calls it a Day
- Three Things That You Should Know About Part 11
- FDA & EMA Regulatory Developments for eSubmissions
- FDA IP Labeling Requirements
- Quantifying Quality for GxP Compliance
- FDA & Politics: In the Interest of Science?
- TMF Reference Model Update
- India: Quality for Clinical Trials
- European Qualified Persons & New EU Anti-Falsification Legislation
- Drug Accountability in Clinical Trials
Twitter Updates
- FDA’s Indifferent Attitude Towards the First Amendment fdamatters.com/?p=2421 1 month ago
- Obama to Unveil Initiative to Map the Human Brain nyti.ms/16hddEM this news while reading "Buddha's Brain" 1 month ago
- HBR.org: Welcome Edits on Your Writing web.hbr.org/mt/032013 2 months ago
- Job opportunity: Principal Quality Systems & Compliance S at Allergan - Orange County, California Area #jobs lnkd.in/aszkef 7 months ago
- Job opportunity: Principal Quality Systems & Compliance S at Allergan - Orange County, California Area #jobs lnkd.in/aszkef 8 months ago
Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 601 other followers
Pages
- About GxP Perspectives
- Articles & Book Reviews
- Guest Commentary
- Guide
- TMF
Blogroll
- 1: U.S. Food & Drug Administration
- 2: FDA, Food Safety, and Related Topics
- 40 top sites from FDAzilla
- 50 Top Blogs for Biotech Students
- Acronym Required
- ACRP NYC
- Applied Clinical Trials Blog
- Art of Getting Well
- Assero
- Audrey's Network
- Aureus Research Newsletter
- Barry A. Friedman, PhD
- Biostatistics and Clinical Trials
- Blog Catalog
- Blog Search Engine
- Business Intelligence Solutions Blog
- Chromosome
- Compliance Zen
- DIA
- diabetes self management
- Diabetes Technology
- EMA GCP Inspections
- EMA: European Medicines Agency
- Eye on FDA
- FDA Law Blog
- FDA Lawyers Blog
- FDA Matters
- FDA Transparency Blog
- FDA: Top 40 Websites & Tweets
- FDAAA
- FierceBiotech
- FiercePharma
- Grab and Keel
- GxP Lifeline- Master Control Newsletter
- Health Canada: Drugs & Health Products
- Hedge Hogs
- High Class Blogs
- High Class Blogs: Business Economy
- Independent Review Consulting. inc.
- LinkedIn Group for GxP Perspectives
- Medical Devices Today
- Monte’s Blog
- Moriah Consultant's Blog
- My Perspective
- Personalized Medicine
- PharmTech Talk
- PhRMA Homepage
- QA Talk
- RAPS
- Rebar Interactive (GCP)
- RegBlog (Penn Law School)
- Scientific Blogging
- Share Save
- site map
- Society for Quality Assurance
- SoCRA
- SOP Writing
- SSKRP Law
- Top Blogging Business
- total blog directory
- Two Decades and Counting
- WordPress.com
- WordPress.org
- WSJ Health Blog
Important References
- 1: U.S. Food & Drug Administration
- 483s by PharmTech Talk
- Bing
- Compliance Program Guidance Manual CP 7348.811
- Computerized Systems Used In Clinical Investigations
- E6: Good Clinical Practice
- EMA GCP Inspections
- FDA Dose Calculator
- FDA NIDPOE Letters
- FDA Ombudsman
- FDA Strategic Plan for Risk
- FDA Warning Letters
- FDA: Epanded Access
- FMD 145
- Health Canada: Drugs & Health Products
- ICH clinical trials guideline
- IRB Compliance Program
- Scope and Application
- The Belmont Report
- The Declaration of Helsinki
- The Nuremberg Code
- Thomas (Library of Congress)
Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 601 other followers
Blog Stats
- 268,758 hits

Archives
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009

Follow

Follow “GxP Perspectives”

Powered by WordPress.com

%d bloggers like this: